Mutations in the ephrin-B1 gene result in craniofrontonasal syndrome (CFNS) in humans, a congenital disorder that includes a wide range of craniofacial, skeletal, and neurological malformations. In addition to the ability of ephrin-B1 to forward signal through its cognate EphB tyrosine kinase receptors, ephrin-B1 can also act as a receptor and transduce a reverse signal by either PDZ-dependent or phosphorylation-dependent mechanisms. To investigate how ephrin-B1 acts to influence development and congenital disease, we generated mice harboring a series of targeted point mutations in the ephrin-B1 gene that independently ablate specific reverse signaling pathways, while maintaining forward signaling capacity. We demonstrate that both PDZ and phosphorylationdependent reverse signaling by ephrin-B1 are dispensable for craniofacial and skeletal development, whereas PDZdependent reverse signaling by ephrin-B1 is critical for the formation of a major commissural axon tract, the corpus callosum. Ephrin-B1 is strongly expressed within axons of the corpus callosum, and reverse signaling acts autonomously in cortical axons to mediate an avoidance response to its signaling partner EphB2. These results demonstrate the importance of PDZ-dependent reverse signaling for a subset of Ephrin-B1 developmental roles in vivo. The capacity for bidirectional signaling is a hallmark of the Eph/ephrin signaling system: In addition to their ability to signal through cognate Eph tyrosine kinase receptors, ephrins can also transduce a reverse signal into the cell in which they are expressed (Davy and Soriano 2005). Bidirectional signaling can occur for both A-and B-type subfamilies, although the mechanisms by which ephrins accomplish this reverse signal differ. Ephrin-As are tethered to the membrane via a GPI linkage, whereas ephrin-Bs are transmembrane molecules and possess a conserved intracellular domain. Ephrin-B1, a member of the B-type subfamily, can bind EphB1-3, although genetic studies comparing phenotypes of mice harboring loss-of-function mutations in the receptors and ligands suggest that EphB2 and EphB3 are the principal receptors for ephrin-B1 in most developmental contexts Compagni et al. 2003;Blits-Huizinga et al. 2004). The capacity for bidirectional signaling was initially identified based on discordances between phenotypes observed in complete loss-of-function mutations of EphB2 compared with mutations in which only the kinase domain of EphB2 was mutated, leaving the extracellular portion intact . Whereas EphB2 homozygous null mutant mice displayed defects in the axon pathfinding of the anterior commissure, EphB2 mutants lacking kinase activity did not display these defects, indicating that kinase activity was not required for EphB2s role in anterior commissure formation . Direct genetic evidence for reverse signaling has since been obtained by the analysis of mutations in B-type ephrins that abrogate reverse signaling while maintaining forward signaling capacity; however, the relative importance and mechanism of action o...